Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article, J Pharmacol Biomed Anal Vol: 1 Issue: 1
Are Both Antidepressant Drug Effects and Test Scores Unspecific?
| Ivar Aursnes1, Ingunn F Tvete3, Jorund Gaasemyr2, Bent Natvig2 and Marianne Klemp1* |
| 1Department of Pharmacology, University of Oslo, Oslo, Norway |
| 2Department of Mathematics, University of Oslo, Oslo, Norway |
| 3Norwegian Computing Center, Oslo, Norway |
| Corresponding author : Marianne Klemp Norwegian Knowledge Centre for the Health Services, PO Box: 7004, St Olavs Plass, Oslo, Norway Tel: +4793419895; Fax: +4723255010 E-mail: marianne.klemp@kunnskapssenteret.no |
| Received: December 10, 2012 Accepted: February 18, 2013 Published: February 22, 2013 |
| Citation: Aursnes I, Tvete IF, Gaasemyr J, Natvig B, Klemp M (2013) Are Both Antidepressant Drug Effects and Test Scores Unspecific? J Pharmacol Biomed Anal 1:1. doi:10.4172/2327-4638.1000102 |
Abstract
Are Both Antidepressant Drug Effects and Test Scores Unspecific?
Background: Disappointingly small clinical effects of antidepressant drugs have recently been reemphasized. It is also unclear to what degree the 17 questions in the Hamilton Rating Scale of Depression and other questionnaires represent true aspects of depression or rather can be said to measure unspecific symptoms.
Methods: Within all clinical study reports concerning citalopram submitted to the Danish Health Authorities before registration in 1988 we identified among 49 studies two studies with placebo groups reporting individual patient scores. A multiple regression analysis was performed by treating questionnaire item no 1 (depressed mood) as the dependent variable and the scores for all other items as potentially explanatory variables. The questionnaire items were sorted in two groups: items with p-value less than 0.05 considered related to depression and items with p-value above 0.05 considered unrelated. By pooling the data together we performed an analysis of the effect size (standardized differences in means; citalopram versus placebo treatment, baseline score minus end score) for each of the two questionnaire groups, as well as for the total HAM-D 17 score.
